Abstract:T cells are activated by an interaction of their TCRs with a complex made up of antigenic peptide bound to the interhelical groove of MHC molecules. The helices lining the antigen binding groove of MHC molecules are felt to contribute several contact residues for TCR binding. Peptides derived from the amino acid sequences of these helices may be capable of modulating immune responses and aiding in the dissection of immune recognition. These studies address the effects of a peptide derived from the sequence of amino acids 68–83 of the IAkβ1 domain (IAk 68–83) predicted to represent a portion of an antigen-binding helix on the IAk molecule. The IAk 68–83 peptide is bound a monoclonal anti-IAk antibody and inhibits its binding to IAk-bearing cells. The IAk 68–83 peptide inhibits antigen-dependent activation of the IAk+con-albumin restricted T cell clone D10.G4, and this effect is more pronounced at lower doses of antigen-presenting cells. The free peptide has a small effect in limiting binding of anticlonotypic antibodies to D10.G4, and a multivalent form bound to BSA has a more pronounced effect in this regard. The BSA-peptide conjugate, when fluoresceinated, specifically stained D10.G4 cells, and this was specifically competed by unfluoresceinated IAk 68–83 peptide-BSA conjugate, as well as by anticlonotype. These results suggest that peptides derived from the predicted helical region of MHC class II molecules may have a direct interaction with T cell receptors. Such peptides may be capable of modulating immune responses in a physiologically significant manner.

Soluble Peptide–mhc Monomers Cause Activation of CD8+T Cells Through Transfer of the Peptide to T Cell MHC Molecules

Class I Negative Cd8 T Cells Reveal the Confounding Role of Peptide-Transfer Onto Cd8 T Cells Stimulated with Soluble H2-K-B Molecules

Mechano-regulation of Peptide-MHC Class I Conformations Determines TCR Antigen Recognition.

T Cell Receptor Signaling Is Limited by Docking Geometry to Peptide-Major Histocompatibility Complex

Modulation of T Cell Responses with MHC-derived Peptides.

T cell activation enhancement by endogenous pMHC acts for both weak and strong agonists but varies with differentiation state

Cis Interactions Between CD2 and Its Ligands on T Cells Are Required for T Cell Activation

High Affinity Xenoreactive TCR:MHC Interaction Recruits CD8 in Absence of Binding to MHC1

Non-Stimulatory pMHC Enhance CD8 T Cell Effector Functions by Recruiting Coreceptor-Bound Lck

Cd8(+) Cytotoxic T-Apc Stimulate Central Memoiry Cd8(+) T Cell Responses Via Acquired Peptide-Mhc Class I Complexes And Cd80 Costimulation, And Rl-2 Secretion

Dependence of Lymphopenia-Induced T Cell Proliferation on the Abundance of Peptide/ MHC Epitopes and Strength of Their Interaction with T Cell Receptors.

Stage-dependent Reactivity of Thymocytes to Self-Peptide–mhc Complexes

Competition for self-peptide-MHC complexes and cytokines between naive and memory CD8+ T cells expressing the same or different T cell receptors.

The TCR/peptide/MHC complex with a superagonist peptide shows similar interface and reduced flexibility compared to the complex with a self-peptide

TCR Recognition of Peptide–MHC-I: Rule Makers and Breakers

The Combination of CD8αα and Peptide-MHC-I in a Face-to-Face Mode Promotes Chicken γδT Cells Response

Modification of peptide interaction with MHC creates TCR partial agonists

Synthetic Peptides with Inadvertent Chemical Modifications Can Activate Potentially Autoreactive T Cells

Canonical T cell receptor docking on peptide–MHC is essential for T cell signaling

Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner

Three-dimensional segregation of supramolecular activation clusters in T cells